ArticlePathology oncology research : POR2024

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Peter Batar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.